- The report introduces a "Total Heat Index" indicator, which is defined as the sum of browsing, self-selection, and click counts of individual stocks, normalized by their market share on the same day, and then multiplied by 10,000. The value range of this indicator is [0, 10,000][7] - The "Total Heat Index" is aggregated at broader levels such as broad-based indices, industries, and concepts, serving as a proxy variable for "sentiment heat" to track market sentiment[7] - A simple rotation strategy is constructed based on the weekly heat change rate (MA2) of broad-based indices. The strategy involves buying the broad-based index with the highest heat change rate on the last trading day of each week. If the "Other" group has the highest change rate, the strategy remains in cash. The annualized return of this strategy since 2017 is 8.74%, with a maximum drawdown of 23.5%, and a return of 31.4% in 2025[13][16] - For concept-level heat, two portfolios are constructed: 1. A "TOP" portfolio selects the top 10 stocks with the highest total heat from the five concepts with the largest heat change rates each week, excluding the bottom 20% of stocks by market capitalization 2. A "BOTTOM" portfolio selects the bottom 10 stocks with the lowest total heat from the same concepts. The "BOTTOM" portfolio has achieved an annualized return of 15.71%, a maximum drawdown of 28.89%, and a return of 40.2% in 2025[29][31] - The heat change rate (MA2) of the "Other" group increased by 1.54% compared to the previous week, while the CSI 1000 index had the lowest change rate, decreasing by 1.98%[16][18] - The report highlights that high-heat concepts often experience rapid price adjustments due to behavioral factors, with the highest-attention stocks in these concepts reacting most quickly in the short term[29]

Core Viewpoint - Tonghua Jinma's stock price has shown significant volatility, with a year-to-date increase of 76.31%, but a recent decline of 3.72% over the last five trading days [1] Group 1: Stock Performance - As of November 26, Tonghua Jinma's stock price was 27.68 CNY per share, with a market capitalization of 26.753 billion CNY [1] - The stock has experienced a trading volume of 73.0787 million CNY, with a turnover rate of 0.28% [1] - The company has appeared on the "龙虎榜" (a trading board for stocks with significant trading activity) twice this year, with the latest appearance on September 11, where it recorded a net buy of 142 million CNY [1] Group 2: Financial Performance - For the period from January to September 2025, Tonghua Jinma reported operating revenue of 892 million CNY, a year-on-year decrease of 7.88%, while net profit attributable to shareholders was 24.9635 million CNY, an increase of 4.35% [2] - The company's main business revenue composition includes biopharmaceuticals (59.27%), traditional Chinese medicine (40.56%), raw materials (0.10%), and others (0.07%) [1] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Tonghua Jinma was 38,200, a decrease of 3.20% from the previous period [2] - The top ten circulating shareholders include notable entities such as Innovation Drug and Southern CSI 1000 ETF, with varying changes in their holdings [3]

Group 1 - The core viewpoint of the news is that Aoyang Health has shown fluctuations in stock performance, with a year-to-date increase of 35.14% but a recent decline in the last five trading days by 5.58% [1] - As of November 25, Aoyang Health's stock price was 4.23 CNY per share, with a market capitalization of 3.239 billion CNY [1] - The company has experienced a net inflow of main funds amounting to 3.5156 million CNY, with significant buying and selling activities noted [1] Group 2 - For the period from January to September 2025, Aoyang Health reported operating revenue of 1.36 billion CNY, a year-on-year decrease of 9.39%, while the net profit attributable to shareholders was 40.1137 million CNY, reflecting a year-on-year increase of 3.71% [2] - The company has a total of 58,300 shareholders as of September 30, which is a decrease of 10.91% from the previous period, while the average circulating shares per person increased by 12.24% to 13,121 shares [2] - Aoyang Health has cumulatively distributed dividends of 26.1 million CNY since its A-share listing, with no dividends distributed in the last three years [3]

Core Viewpoint - Hengfeng Paper's stock price has experienced fluctuations, with a year-to-date increase of 22.77% but a recent decline in the last five and twenty trading days [1][2]. Company Overview - Hengfeng Paper, established on March 6, 1994, and listed on April 19, 2001, is located in Mudanjiang, Heilongjiang Province. The company specializes in the production and sale of specialty papers, including cigarette paper, filter rod paper, and aluminum foil lining paper [1]. - The revenue composition of Hengfeng Paper includes 65.48% from tobacco industrial paper, 15.50% from other paper types, 11.75% from mechanical gloss paper, 6.08% from thin printing paper, and 1.19% from other sources [1]. Financial Performance - As of September 30, 2025, Hengfeng Paper reported a revenue of 2.039 billion yuan, reflecting a year-on-year growth of 6.29%. The net profit attributable to shareholders was 148 million yuan, marking a significant increase of 34.76% compared to the previous year [2]. - The company has distributed a total of 680 million yuan in dividends since its A-share listing, with 115 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Hengfeng Paper was 14,600, a decrease of 12.06% from the previous period. The average circulating shares per person increased by 13.71% to 20,445 shares [2]. - Notable new institutional shareholders include the Jiangyin State-owned Enterprise Reform Flexible Allocation Mixed A Fund, which holds 5.6999 million shares, and the招商量化精选股票发起式A Fund, holding 4.3094 million shares [3].

11月17日，通化金马盘中上涨2.23%，截至11:05，报29.39元/股，成交3.93亿元，换手率1.41%，总市值 284.05亿元。 资金流向方面，主力资金净流出1759.63万元，特大单买入2862.41万元，占比7.28%，卖出4253.98万 元，占比10.82%；大单买入1.15亿元，占比29.36%，卖出1.19亿元，占比30.29%。 通化金马所属申万行业为：医药生物-化学制药-化学制剂。所属概念板块包括：民营医院、工业大麻、 东北振兴、肝炎治疗、中药等。 截至9月30日，通化金马股东户数3.82万，较上期减少3.20%；人均流通股25266股，较上期增加3.31%。 2025年1月-9月，通化金马实现营业收入8.92亿元，同比减少7.88%；归母净利润2496.35万元，同比增长 4.35%。 分红方面，通化金马A股上市后累计派现2.10亿元。近三年，累计派现0.00元。 机构持仓方面，截止2025年9月30日，通化金马十大流通股东中，创新药（159992）位居第七大流通股 东，持股919.30万股，相比上期增加8.78万股。南方中证1000ETF（512100）位居第八大流通股东，持 ...

Core Viewpoint - The stock of Shouxiangu has shown a slight increase in recent trading sessions, with a notable rise in trading volume and a positive net inflow of funds, indicating investor interest despite a decline in revenue and profit year-on-year [1][2]. Company Overview - Shouxiangu Pharmaceutical Co., Ltd. is located in Wuyi County, Zhejiang Province, and was established on March 3, 1997. It was listed on May 10, 2017. The company specializes in the breeding, cultivation, processing, and sales of valuable traditional Chinese medicinal materials such as Ganoderma and Dendrobium [2]. - The main business revenue composition includes: Ganoderma spore powder products (71.92%), Dendrobium products (15.57%), other products (10.88%), and supplementary products (1.63%) [2]. Stock Performance - As of November 14, the stock price of Shouxiangu increased by 2.16%, reaching 21.30 CNY per share, with a trading volume of 33.55 million CNY and a turnover rate of 0.80%. The total market capitalization is 4.22 billion CNY [1]. - Year-to-date, the stock price has risen by 1.72%, with a 3.60% increase over the last five trading days, a 3.40% increase over the last 20 days, and a 3.75% decrease over the last 60 days [2]. Financial Performance - For the period from January to September 2025, Shouxiangu reported a revenue of 430 million CNY, a year-on-year decrease of 8.88%. The net profit attributable to the parent company was 76.34 million CNY, down 35.67% year-on-year [2]. - Since its A-share listing, Shouxiangu has distributed a total of 436 million CNY in dividends, with 218 million CNY distributed in the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Shouxiangu was 22,700, a decrease of 4.31% from the previous period. The average circulating shares per person increased by 4.51% to 8,727 shares [2]. - Among the top ten circulating shareholders, the Rongtong Health Industry Flexible Allocation Mixed A/B fund holds 1.2823 million shares, an increase of 82,300 shares compared to the previous period [3].

Core Viewpoint - Jifeng Technology's stock price has seen a significant increase of 65.55% year-to-date, despite a recent decline of 2.09% in intraday trading on November 14, 2023, indicating volatility in the market [1]. Group 1: Stock Performance - As of November 14, 2023, Jifeng Technology's stock price is reported at 8.89 CNY per share, with a market capitalization of 4.394 billion CNY [1]. - The stock has experienced a trading volume of 40.47 million CNY, with a turnover rate of 0.91% [1]. - Year-to-date, the stock has increased by 65.55%, with a 3.37% rise over the last five trading days, 1.48% over the last 20 days, and 3.86% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Jifeng Technology reported a revenue of 2.224 billion CNY, reflecting a year-on-year growth of 3.47% [2]. - The company recorded a net profit attributable to shareholders of -7.315 million CNY, which represents a year-on-year increase of 69.62% [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Jifeng Technology has increased to 21,300, marking a rise of 9.68% from the previous period [2]. - The average number of circulating shares per shareholder is 23,206, which has decreased by 8.83% compared to the previous period [2]. - Since its A-share listing, Jifeng Technology has distributed a total of 53.61 million CNY in dividends, with no dividends paid in the last three years [3]. Group 4: Company Overview - Jifeng Technology, established on December 8, 1994, and listed on October 30, 2009, is based in Chengdu, Sichuan Province, and specializes in the sales and services of modern agricultural equipment, including agricultural machinery, cargo vehicles, and engineering machinery [1]. - The company's revenue composition indicates that 90.33% comes from the agricultural machinery distribution segment, while 9.67% is from the agricultural machinery manufacturing segment [1]. - Jifeng Technology is categorized under the Shenyin Wanguo industry classification of retail trade - professional chain II - professional chain III, and is associated with concepts such as rural revitalization, ecological agriculture, rural e-commerce, industrial hemp, and supply cooperative concepts [1].

Group 1 - The core viewpoint of the news is that Sanlisi's stock has shown positive performance with a year-to-date increase of 10.49% and a recent uptick of 4.41% over the last five trading days [1] - As of November 13, Sanlisi's stock price reached 4.74 yuan per share, with a total market capitalization of 4.276 billion yuan [1] - The company has seen a net inflow of main funds amounting to 8.2264 million yuan, indicating strong investor interest [1] Group 2 - For the period from January to September 2025, Sanlisi achieved an operating income of 714 million yuan, reflecting a year-on-year growth of 21.75% [2] - However, the net profit attributable to shareholders decreased by 45.76% to 27.6511 million yuan during the same period [2] - The number of shareholders increased slightly to 51,200, while the average circulating shares per person decreased by 0.02% to 15,742 shares [2] Group 3 - Since its A-share listing, Sanlisi has distributed a total of 463 million yuan in dividends, with 89.7271 million yuan distributed over the past three years [3]

Company Overview - Qizhou Dongfeng New Materials Group Co., Ltd. is located in Shantou, Guangdong Province, and was established on December 30, 1983. The company was listed on February 16, 2012. Its main business involves the design, production, and sales of cigarette labels and related packaging materials [1][2]. Financial Performance - For the period from January to September 2025, Qizhou Dongfeng achieved operating revenue of 916 million yuan, a year-on-year decrease of 12.54%. The net profit attributable to the parent company was -95.4971 million yuan, representing a year-on-year increase of 49.83% [2]. - The company has cumulatively distributed 4.134 billion yuan in dividends since its A-share listing, with a total of 46.0741 million yuan distributed over the past three years [3]. Stock Performance - As of November 13, Qizhou Dongfeng's stock price increased by 2.05%, reaching 4.97 yuan per share, with a total market capitalization of 9.262 billion yuan. The stock has risen by 24.87% year-to-date, with a recent decline of 0.40% over the last five trading days [1]. - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on January 24 [1]. Shareholder Information - As of September 30, 2025, the number of shareholders for Qizhou Dongfeng was 31,500, a decrease of 11.45% from the previous period. The average circulating shares per person increased by 12.28% to 59,077 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 11.9868 million shares, a decrease of 932,700 shares compared to the previous period [3]. Industry Classification - Qizhou Dongfeng is classified under the light industry manufacturing sector, specifically in packaging and printing, with a focus on paper packaging. The company is associated with concepts such as low price, state-owned enterprise reform, small-cap stocks, industrial hemp, and margin financing [2].

Core Viewpoint - Yunnan Chengtou's stock price has shown a slight increase this year, but recent trading data indicates a net outflow of funds, suggesting potential investor concerns about the company's performance and market position [1][2]. Financial Performance - For the period from January to September 2025, Yunnan Chengtou reported operating revenue of 1.336 billion yuan, a year-on-year decrease of 2.97% [2]. - The company recorded a net profit attributable to shareholders of -35.22 million yuan, representing a significant year-on-year decline of 296.01% [2]. Stock Market Activity - As of November 12, Yunnan Chengtou's stock price was 2.72 yuan per share, with a market capitalization of 4.367 billion yuan [1]. - The stock has increased by 1.87% year-to-date, with a 0.74% rise over the last five trading days, a 5.02% increase over the last 20 days, and a 9.68% increase over the last 60 days [1]. Shareholder Information - As of October 31, the number of shareholders for Yunnan Chengtou was 54,200, an increase of 3.25% from the previous period [2]. - The average number of circulating shares per shareholder was 29,629, a decrease of 3.15% from the previous period [2]. Dividend History - Since its A-share listing, Yunnan Chengtou has distributed a total of 707 million yuan in dividends, with no dividends paid in the last three years [3]. Institutional Holdings - As of September 30, 2025, the sixth largest circulating shareholder was the Southern CSI Real Estate ETF, holding 12.1863 million shares, which is a decrease of 82,200 shares from the previous period [3].